Barbas, A., Lamy, M., Ferreira, A., Galvão, J., Braga, S., Bandeiras, T., & Silva, G. (2016). Development of novel biotherapeutics for breast cancer: generation of function blocking antibodies against Notch1 ligands. In New Biotechnology (Vol. 33, pp. S47–S47). Elsevier BV. https://doi.org/10.1016/j.nbt.2016.06.889

Barbas, Ana, Márcia Lamy, Andreia Ferreira, Joana Galvão, Sofia Braga, Tiago Bandeiras, and Gabriela Silva. “Development of novel biotherapeutics for breast cancer: generation of function blocking antibodies against Notch1 ligands.” In New Biotechnology, 33:S47–S47. Elsevier BV, 2016. https://doi.org/10.1016/j.nbt.2016.06.889.

Barbas A, Lamy M, Ferreira A, Galvão J, Braga S, Bandeiras T, et al. Development of novel biotherapeutics for breast cancer: generation of function blocking antibodies against Notch1 ligands. In: New Biotechnology. Elsevier BV; 2016. p. S47–S47.

Barbas, Ana, et al. “Development of novel biotherapeutics for breast cancer: generation of function blocking antibodies against Notch1 ligands.” New Biotechnology, vol. 33, Elsevier BV, 2016, pp. S47–S47. Crossref, doi:10.1016/j.nbt.2016.06.889.

Barbas A, Lamy M, Ferreira A, Galvão J, Braga S, Bandeiras T, Silva G. Development of novel biotherapeutics for breast cancer: generation of function blocking antibodies against Notch1 ligands. New Biotechnology. Elsevier BV; 2016. p. S47–S47.